Get notified when AEMD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Warrants to Purchase 5,633,009 Shares of Common Stock (new) — The offering includes a large number of warrants relative to the primary share count, creating significant potential dilution if exercised.
- Placement Agent Warrants to Purchase 225,320 Shares of Common Stock (new) — Placement agent warrants add further dilution and are a cost of the offering borne by existing shareholders.
Aethlon Medical prices $187K best-efforts offering of 263,000 shares at $0.71, plus warrants
Filed July 7, 2026 · ~1 min read
Key Changes
-
high
Aethlon Medical is offering 263,000 shares of common stock at $0.71 per share in a best-efforts offering, with gross proceeds of approximately $187,000 before fees.
The Offering verify on EDGAR → -
medium
The offering also includes pre-funded warrants to purchase 5,370,009 shares and common warrants to purchase 5,633,009 shares, each with an exercise price of $0.71 per share.
The Offering verify on EDGAR → -
medium
Common warrants are exercisable only upon stockholder approval or if certain pricing conditions are met, adding uncertainty to future dilution.
The Offering verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade AEMD commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify